Editorials

Expandable metal stents in malignant colorectal obstruction

BMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7261.584 (Published 09 September 2000) Cite this as: BMJ 2000;321:584

Promising, but trials are needed on safety and cost effectiveness

  1. Tariq Ahmad, research fellow,
  2. Anthony S Mee, consultant gastroenterologist
  1. Department of Gastroenterology, Radcliffe Infirmary, Oxford OX2 6HE
  2. Department of Gastroenterology, Royal Berkshire Hospital, Reading RG1 5AN

    There are an estimated 300 000 new cases of colorectal cancer detected in Europe and the United States each year; 7-29% of these cases present with complete or partial obstruction of the large bowel. 1 2 Patients who present with obstruction have a five year survival rate of less than 20%, a far poorer prognosis than patients who present without obstruction.2 This poor outlook reflects not only the more advanced stage of carcinomas that cause obstruction40% of these patients have metastatic disease at presentation—but also the greater risks associated with emergency decompressive surgery in elderly people.3

    Despite the increasing popularity of primary resection and anastomosis, most surgeons still advocate the traditional two stage procedure which creates a temporary stoma. In patients found to have advanced disease this stoma is likely to become permanent. Only about 20% of these patients will survive for one year after this palliative surgery.2 For patients with “curable” disease there is the option of elective re-anastomosis. Many elderly patients and their surgeons are deterred from the second closure operation because it can lead to morbidity or death; thus …

    View Full Text

    Sign in

    Log in through your institution

    Subscribe